# US 2017/0290917 A1 · Engineered microparticles for macromolecule delivery

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0290917 A1
- Document ID: US20170290917A1
- Status: Published application
- Kind: A1
- Application number: 15/494,127
- Filed: 2017-04-21
- Published: 2017-10-12
- Earliest claimed: 2009-09-10
- Assignees: University of Pittsburgh—Of the Commonwealth System of Higher Education
- Applicants: University of Pittsburgh - Of the Commonwealth System of Higher Education
- Inventors: Steven R. Little; Sam N. Rothstein
- Web page: https://patentgrep.com/patent/US20170290917A1

## CPC

- A61K 47/34: Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers (A61K47/10 takes precedence)
- A61K 9/1647: {Polyesters, e.g. poly(lactide-co-glycolide)}
- A61K 9/1694: {resulting in granules or microspheres of the matrix type containing more than 5% of excipient}
- A61K 9/48: Preparations in capsules, e.g. of gelatin, of chocolate {(A61K9/0004 takes precedence; bite capsules A61K9/0056)}
- G16B 5/30: Dynamic-time models
- G16B 15/00: ICT specially adapted for analysing two-dimensional [2D] or three-dimensional [3D] molecular structures, e.g. structural or functional relations or structure alignment
- G16B 50/20: Heterogeneous data integration
- G16B 50/30: Data warehousing; Computing architectures
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

A method for making a modified release composition, comprising: selecting a desired active agent and polymer matrix for formulating into a modified release composition; assessing degradation effect on release of the active agent from the composition including plotting polymer molecular weight (Mwr) at onset of active agent release vs. active agent molecular weight (MwA); predicting performance of multiple potential formulations for the composition based on the degradation assessment and average polymer matrix initial molecular weight (Mwo) to define a library of building blocks; determining the optimal ratio of the building blocks to satisfy a specified release profile; and making a modified release composition based on the optimal ratio determination.

## Claims

### Claim 1

A computer-implemented method comprising:
receiving, by a processor, a dissolution rate for a formulation containing an active agent;
assessing, by the processor, dissolution rates for sample formulations containing at least one hydrolys able polymer and the active agent based on properties of each of the at least one hydrolys able polymer and properties of the active agent; and
generating, by the processor, a formulation containing the at least one hydrolys able polymer and the active agent, wherein the formulation has a dissolution rate corresponding to the dissolution rate.

### Claim 2 (depends on 1)

The method of claim 1, wherein the properties for each of at least one hydrolysable polymer are selected from the group consisting of initial molecular weights (Mwo) and polymer degradation rates (kCw).

### Claim 3 (depends on 1)

The method of claim 1, wherein the step of identifying formulations comprises:
performing, by the processor, non-linear optimization on one or more formulations to determine the percent total composition of each of the at least one hydrolysable polymer in each formulation;
eliminating, by the processor, each formulation having the percent total composition of less than 1 percent for at each least one hydrolysable polymer;
repeating the step of performing non-linear optimization and eliminating each formulation until a percent change of greater than 5 percent is reached or one formulation remains.

### Claim 4 (depends on 1)

The method of claim 1, wherein the formulation defines a composition that is a sustained release pharmaceutical composition.

### Claim 5 (depends on 1)

The method of claim 1, wherein the active agent is a bioactive agent or a therapeutic agent.

### Claim 6 (depends on 1)

The method of claim 1, wherein each at least one hydrolysable polymer is selected from the group consisting of poly(glycolic acid), poly(lactic acid), poly(lactide-co-glycolide), polyanhydride, poly(α-hydroxy ester), poly(β-hydroxy ester), poly(ortho ester), and mixtures thereof.

### Claim 7 (depends on 1)

The method of claim 1, wherein the formulation defines a medicament.

### Claim 8 (depends on 7)

The method of claim 7, wherein the medicament comprises at least two populations of microparticles.

### Claim 9 (depends on 7)

The method of claim 7, wherein the medicament is selected from the group consisting of matrix tablets, enteric coated tablets, single and double coated tablets, capsules, minitablets, caplets, coated beads, granules, spheroids, pellets, microparticles, suspensions, topicals, injectables, inhalable compositions, and implants.

### Claim 10 (depends on 1)

The method of claim 1, further comprising making a composition based on the formulation.

### Claim 11 (depends on 1)

The method of claim 1, wherein the properties of the active agent are selected from an agent's molecular weight (MwA), aqueous solubility, isoelectric point, and combinations thereof.

### Claim 12 (depends on 1)

The method of claim 1, wherein predicting a dissolution rate further comprises determining a mean time for pore formation (τ) based on the physical properties of each at least one hydrolysable polymer.

### Claim 13 (depends on 12)

The method of claim 12, further comprising determining a variance (σ2) in induction time distribution for pore formation (ε(t)).

### Claim 14 (depends on 13)

The method of claim 13, wherein determining the variance (σ2) further comprises determining a distribution of polymer degradation rates (kCw(n)) attributed to crystallinity of each at least one hydrolysable polymer.

### Claim 15 (depends on 1)

The method of claim 1, wherein predicting the dissolution rate further comprises determining a diffusivity of the active agent (D) from each at least one hydrolysable polymer.

### Claim 16 (depends on 1)

The method of claim 1, wherein predicting a dissolution rate further comprises determining a molecular weight at release (Mwr) for each at least one hydrolysable polymer based on the physical properties of the at least one active agent.

### Claim 17 (depends on 13)

The method of claim 13, wherein the molecular weight at release (Mwr) is determined based on a molecular weight of the at least active agent (MwA) encapsulated by each at least one hydrolysable polymer.
